The company seeks to identify, manage, and mitigate risks to its business, recognizing that uncertainties and risks are difficult to predict and many are outside of its control. The company has robust business continuity plans in place across its global supply chain network to help mitigate the impact of COVID-19, although these efforts may not completely prevent adverse effects on the business. The company continues to leverage its global manufacturing footprint and dual-source capabilities while closely monitoring and maintaining critical inventory at major distribution centers to ensure adequate and effective distribution. The company's diversified business model across the healthcare industry is designed with flexibility in its manufacturing, research and development, clinical operations, and commercial capabilities. The company has put procedures in place to protect its essential workforce while ensuring appropriate remote working protocols for other employees. The company's high-quality credit rating allows superior access to financial capital markets, which is crucial for maintaining liquidity during challenging conditions. The company has considered various internal and external factors in assessing the potential impact of COVID-19 on its business and financial results. The company continues to monitor the situation and adapt its operations as necessary, demonstrating a commitment to resilience strategies that address the evolving needs of society. The company’s operational flexibility enables it to respond effectively to environmental disruptions and maintain its performance under pressure. The company is aware that its products are used in an environment where policymakers, consumers, and businesses have expressed concerns about the rising cost of healthcare, prompting a long-standing policy of pricing products responsibly. The company strives to maintain profit margins through cost reduction programs, productivity improvements, and periodic price increases in response to inflationary pressures. The company’s commitment to innovation is reflected in its significant investments in research and development, which are essential for addressing the evolving healthcare needs of patients, providers, and consumers. The company recognizes the importance of effective succession planning and the transfer of knowledge among key employees to ensure organizational continuity and resilience. The company’s ability to foresee and confront sudden disruptive changes is critical for its survival and growth. The company is subject to various legal proceedings that can result in significant expenses and reputational damage, which necessitates careful management of legal contingencies and proactive measures to mitigate risks. The company’s extensive information security and cybersecurity investments are aimed at addressing the threats to the security and availability of its systems and networks, ensuring operational continuity. The company’s organizational practices are designed to enhance its adaptability and responsiveness to complex situations, thereby supporting its long-term success and resilience in a turbulent market environment.